HEALTH TECHNOLOGY

HCA Healthcare Strengthens Partnership with Tennessee State University

HCA Healthcare, Inc. | October 07, 2022 | Read time : 04:00 min

HCA Healthcare

HCA Healthcare, Inc. one of the nation’s leading healthcare providers, announced that it will give $1.5 million to Tennessee State University to create scholarship opportunities for students enrolled in the Dr. Levi Watkins, Jr. Institute and the Department of Computer Science within the College of Engineering. This gift is part of the organization’s larger commitment to give $10 million over three years to Historically Black Colleges and Universities (HBCUs) and Hispanic Serving Institutions. Since making the pledge in 2021, HCA Healthcare has announced approximately $5.25 million in donations towards multiple partnerships.

We are proud of the long-standing relationship we have fostered with TSU. By strengthening our partnership, we will be able to create additional opportunities for TSU students and further our commitment to advancing diversity in healthcare.”

Sam Hazen, chief executive officer for HCA Healthcare

Funds from this gift will support scholarships for students participating in the university’s Dr. Levi Watkins, Jr. Institute Accelerated Medical Pathway program. Three two-year scholarships for rising juniors and three two-year scholarships for graduate students within the College of Engineering will also be awarded. Through these scholarship programs, HCA Healthcare Scholars and HCA Healthcare ITG Scholars will be provided with hands on shadowing opportunities, mentors, seminars, leadership sessions, guest speakers and career guidance. HCA Healthcare will also offer dedicated internship opportunities in the ITG Pathways, Technical Resident and Part-Time Internship programs annually to TSU students.

“It is an honor to partner with TSU to support more students pursuing careers in healthcare and, in turn, helping to build a diverse talent pipeline of healthcare professionals,” said Sherri Neal, chief diversity officer of HCA Healthcare. “Increasing the diversity of our healthcare workforce is vital to providing equitable, culturally competent care to our communities.”

HCA Healthcare has a history of partnering with TSU. In 2015, HCA Healthcare gave $1 million to TSU to fund internship opportunities and support the growth of the Health Information Management program. Marty Paslick, chief information officer for HCA Healthcare, serves as an advisory board member for the College of Engineering where there are currently seven HCA Healthcare colleagues serving as adjunct faculty.

“We applaud and thank HCA Healthcare for this generous gift and continued support of TSU, and our talented students,” said Glenda Glover, president of Tennessee State University. “This investment in our students helps them to become the future doctors and health technology leaders they aspire to be. HCA Healthcare is making their dreams a reality.”

HCA Healthcare is committed to partnering with organizations to help develop a diverse pool of future healthcare leaders. Included among these partnerships is $750,000 to The University of Texas at El Paso to create multiple graduate-degree opportunities for students interested in healthcare careers. The company also gifted $1.5 million to Florida International University’s (FIU) Nicole Wertheim College of Nursing & Health Sciences (NWCNHS) to expand its faculty, offer scholarships to increase enrollment and help address the national nursing shortage. In 2021, HCA Healthcare announced a $1.5 million investment in Florida A&M University’s (FAMU) School of Allied Health Sciences to strengthen students’ pathways from undergraduate to graduate to management careers in the healthcare industry. In 2019, the HCA Healthcare Scholars at Fisk University program was created to provide scholarships, career planning support and internship opportunities for high-achieving undergraduates. These partnerships and others with industry- and school-based associations are part of HCA Healthcare’s continued efforts to strengthen the diversity of the organization’s talent pipeline.

About HCA Healthcare
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 182 hospitals and approximately 2,300 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its more than 35 million annual patient encounters to advance science, improve patient care and save lives.

About Tennessee State University
Founded in 1912, Tennessee State University is Nashville’s only public university, and is a premier, historically black university and land-grant institution offering 39 bachelor’s degree programs, 25 master’s degree programs, one education specialist degree, and eight doctoral degrees. TSU is a comprehensive research intensive institution with a R-2 Carnegie designation, and has a graduate school on its downtown Avon Williams Campus, along with the Otis Floyd Nursery Research Center in McMinnville, Tennessee. With a commitment to excellence, Tennessee State University provides students with a quality education in a nurturing and innovative environment that prepares them as alumni to be global leaders in every facet of society.

Spotlight

The aim of this report, which can be considered a follow-up to the 2017 OECD report, is to examine the economics of patient safety specifically in primary and ambulatory care given (a) the growing importance of this setting in maintaining population health against the background of health and financial challenges, and (b) its critical role in ensuring the sustainability and resilience of the broader health system.

Spotlight

The aim of this report, which can be considered a follow-up to the 2017 OECD report, is to examine the economics of patient safety specifically in primary and ambulatory care given (a) the growing importance of this setting in maintaining population health against the background of health and financial challenges, and (b) its critical role in ensuring the sustainability and resilience of the broader health system.

Related News

HEALTH TECHNOLOGY

Health Catalyst Announces New Leadership Assignments in Support of Strategic Focus Areas

Health Catalyst | September 08, 2022

Health Catalyst, Inc. a leading provider of data and analytics technology and services to healthcare organizations announced three new leadership assignments in support of its strategic focus areas moving forward. These strategic focus areas center around strengthening and deepening existing client relationships to enable greater success in realizing massive, measurable, data-informed improvement while continuing to add new client relationships. This strategic focus includes the appointment of the company's current Chief Revenue Officer, Kevin Freeman, as Chief Growth Officer, and current Chief Brand and Communications Officer, Tarah Neujahr Bryan, as Chief Marketing Officer, effective September 7, 2022. In these roles, Kevin and Tarah will be responsible for the strategic growth functions at Health Catalyst, with a primary focus on expanding existing client relationships, and Kevin and Tarah will each report directly to Chief Executive Officer Dan Burton. Kevin Freeman came to Health Catalyst in 2020 as part of the Vitalware acquisition, bringing 20+ years of healthcare IT growth leadership experience including publicly traded, private equity, and venture-capital-backed companies. He has a successful track record of building results-driven teams, strengthening client partnerships, and driving business development growth. Kevin has a Bachelor of Arts in Sociology from the University of Texas at Arlington. Tarah Neujahr Bryan joined Health Catalyst in 2013 and has served as Editorial Director, Senior Vice President of Marketing, and Chief Brand and Communications Officer. She brings a breadth of marketing and communications experience to her current role. Prior to joining Health Catalyst, Tarah served as the Marketing Communications Director and the Foundation Executive Director at a community hospital, managed at an advertising agency, was the Editor and Operations Manager at an archaeology firm, and provided triage assistance and patient admissions at a Level-II Trauma Center. She has a Master of Arts in Journalism and Mass Communications from the University of Nebraska and a Bachelor of Arts from Montana State University-Billings. Health Catalyst has also named Dave Ross, current Associate Chief Technology Officer, as Chief Technology Officer, also effective September 7, 2022. He will play a critical technology leadership role in building and enabling a world-class data and analytics infrastructure to support clients' efforts towards massive improvement in critical use-case areas such as tech-enabled outsourcing, financial empowerment, population health, and clinical improvement. Dave Ross joined Health Catalyst in 2021 as part of the Twistle acquisition, and was previously the Chief Technology Officer and Co-Founder of Twistle, leading all product development and engineering activities for over ten years prior to Twistle being acquired by Health Catalyst. Before starting Twistle, Dave was the Director of Information Systems at Albany Medical Center in New York. He has built and led software development initiatives across healthcare and educational technology sectors and is passionate about finding the perfect intersection between engineering excellence and delivering business value. Dave holds a Bachelor of Science in Information Systems from SUNY Empire State College. "This is a pivotal time for Health Catalyst as we work toward enabling the positive transformation of care for every patient served by our healthcare clients. I am grateful for each of these three world-class leaders moving into key positions, providing them with an increased opportunity to deliver on our long-term growth and vision to sustain our critical mission of being a catalyst, in deep partnership with our clients, to enable massive, measurable, data-informed healthcare improvement." Chief Executive Officer Dan Burton Related to the new growth leadership assignments, effective September 30, 2022, Patrick Nelli will transition from his role as President to that of Senior Advisor, where he will primarily focus on enabling a smooth transition of his prior responsibilities as President to Kevin Freeman, Chief Growth Officer, and to Dan Burton, Chief Executive Officer. Patrick joined Health Catalyst in 2013 and has played various roles contributing to the company's success, including as Chief Financial Officer from 2017 to January 2021, and as President from January 2021 to the present. Also, effective September 30, 2022, Bryan Hinton will complete his tenure at Health Catalyst. Bryan has contributed to Health Catalyst's growth and success in a number of roles since he joined the company in 2012, including most recently in the role of Chief Technology Officer. Dan Burton shared, "I want to extend my heartfelt gratitude to Patrick and to Bryan for their many years of service and dedication to our mission, and for their incredible expertise and leadership in various roles over the years. They have deeply contributed to our company's mission, growth, and success. We are truly grateful to these outstanding colleagues, and we wish them continued success in their future endeavors." About Health Catalyst Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Read More

HEALTH TECHNOLOGY

Redox and Intelligent Medical Objects Partnering to Augment Healthcare Data

Redox Inc. | October 18, 2022

Redox, the company setting the stage for composable healthcare, has partnered with Intelligent Medical Objects, a healthcare data enablement company to standardize clinical data from diverse systems into consistent, structured, clinically validated terminology including comprehensive mapping to major global coding systems. Now healthcare companies can spend more time building improved patient and clinician experiences by eliminating the lengthy and taxing process of combining multiple point solutions. This announcement comes directly after last week's launch of API Actions, a modular way for healthcare companies to build out their ideal workflows. This present partnership between IMO and Redox benefits any healthcare company that receives clinical problem or diagnosis data from multiple organizations. As a result, these are further able to enrich healthcare data using consistent terminology across all data standards, formats, and workflows with a single Redox API. "Redox is dedicated to making sure that healthcare data can empower builders to create new experiences for patients and providers. We want to be clear that composable healthcare is a practice of bringing together the best technologies to produce the best solutions, and we're glad to be doing so with IMO." Redox CEO Luke Bonney "Clinical patient data is a powerful resource in healthcare. IMO partnering with Redox will accelerate the ability for healthcare companies to leverage that data to create better outcomes for doctors and patients," said IMO CEO Ann Barnes. Redox will leverage IMO's technology to standardize healthcare data for its customers. Using IMO Precision Normalize will allow Redox to accelerate data normalization for its hospital and software vendor clients. This lets healthcare technology companies spend more time building powerful solutions by eliminating the lengthy and costly process of cleaning and standardizing messy clinical data. SNOMED® is a registered trademark of International Health Terminology Standards Development Organisation About Redox Payers, providers, digital health companies, and other healthcare entities use Redox to produce differentiated experiences for patients and clinicians. Connecting to more than 30,000 healthcare organizations, Redox provides a composable software experience across the healthcare ecosystem. With our single API, product teams are empowered to build whatever they can imagine. Redox accelerates innovations that make healthcare data more useful than ever before. About IMO Intelligent Medical Objects is a healthcare data enablement company. From clinical documentation at the point of care to complex approaches to population health management, IMO ensures clinical data integrity and quality—making patient information fit-for-purpose across the healthcare ecosystem. For almost three decades, IMO's footprint in EHRs—across more than 4,500 US hospitals—powers our expert ability to capture and preserve clinical intent wherever and however data is used. Our primary clients span individual doctors and physician groups, hospitals and clinics, large integrated delivery networks, inpatient ORs and surgical centers, global electronic health record providers, health information exchanges, clinical data registries, payers, life sciences companies, and healthcare analytics vendors.

Read More

HEALTH TECHNOLOGY

McKesson Signs Agreement to Acquire Rx Savings Solutions

McKesson Corporation | September 20, 2022

McKesson Corporation announced that it has signed a definitive agreement to acquire Rx Savings Solutions a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers, reaching more than 17 million current patients. The transaction is valued up to $875 million, which includes a $600 million upfront payment and a maximum of $275 million of consideration contingent upon RxSS’ financial performance through calendar year 2025. The transaction is subject to customary closing conditions, including regulatory review, and is expected to close in the second half of Fiscal 2023. “Rx Savings Solutions’ offerings for employers and patients will strengthen McKesson’s ability to help solve the most common medication challenges related to access, affordability and adherence. We expect the acquisition of Rx Savings Solutions to accelerate McKesson’s growth priority in biopharma services by extending our ecosystem of differentiated medication access solutions to patients. Together with Rx Savings Solutions, McKesson will amplify our efforts to advance health outcomes for all.” Brian Tyler, chief executive officer, McKesson “This combination brings together two highly complementary organizations with closely aligned goals and values. By joining McKesson, we will be able to offer an exceptionally broad set of services to our clients and strengthen our leadership in prescription price transparency,” said Michael Rea, a clinical pharmacist who founded and currently leads Rx Savings Solutions. “This is a critical part of our growth journey, and we are excited about what the future holds for Rx Savings Solutions as part of McKesson.” RxSS contracts directly with health plans and large self-funded employers to maximize the effectiveness of benefit design to drive prescription cost savings for members. The company uses an evidence-based, proprietary machine-learning algorithm to help members understand available options for therapy and identify cost-effective prescription alternatives under their insurance. If a prescription change would benefit the member, RxSS provides assistance to update the prescription. The company also provides ongoing medication reminders to help improve adherence. Following the closing of the transaction, RxSS will become part of the company’s Prescription Technology Solutions business, which works across the healthcare delivery system to offer next-generation patient access, affordability and adherence solutions. The combined organization will endeavor to bring new capabilities for employers and patients to McKesson’s broad portfolio of pharmacy, provider, payer, and biopharma services. After initial integration, McKesson expects to use the combined medication access, affordability, and adherence services as a foundation to build new outcomes management programs for biopharma and payers, differentiated by their reach and efficacy at three touchpoints: provider office, pharmacy counter, and direct patient tools. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help make quality care more accessible and affordable. Learn more about how McKesson is impacting virtually every aspect of healthcare at McKesson.com and read Our Stories. About Rx Savings Solutions Founded by pharmacist Michael Rea, Rx Savings Solutions helps members and payers reduce prescription drug costs through a combination of clinical technology, transparency, member engagement and concierge support. Currently 17 million members have access to personalized recommendations for lowering prescription costs and dedicated pharmacy experts to help navigate benefits, providers and pharmacies.

Read More